NCT02576249View on ClinicalTrials.gov

Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions

Osteoarthritis

Interventions

DRUG

Ropivacaine

4cc 0.5% ropivacaine

DRUG

Normal saline

4cc of sterile normal saline (0.9%)

DRUG

Methylprednisolone

1cc 40mg methylprednisolone

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER